Chemicals News and Research

RSS

NovaSterilis awarded patent for sterilization process for pharmaceutical API using supercritical carbon dioxide

NovaSterilis Inc., a developer of supercritical carbon dioxide technology, has been granted US Patent 8,012,414 B2. The patent, dated September 6, 2011 entitled “Sterilization of Drugs Using Supercritical Carbon Dioxide Sterilant”, covers a new and effective method of sterilizing pharmaceutical product without dangerous chemicals or radiation.

11 Oct 2011

Aspirin desensitization procedure can benefit patients with sinusitis, asthma and AERD

Beth Moore can now keep up with her children. The suburban Philadelphia mother of two had suffered from allergies and chronic sinusitis since her teens. With age her symptoms became more severe, turning into bronchitis and eventually asthma, diminishing her ability to breathe and sapping her of her energy. The only complete relief came from aspirin; and the aspirin desensitization that allowed her to overcome her aspirin allergy and end her decades-long battle with sinusitis.

11 Oct 2011

New siRNA treatment reduces damaging inflammation in animals models of several disorders

Massachusetts General Hospital (MGH) researchers - along with collaborators from Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals - have found a way to block, in an animal model, the damaging inflammation that contributes to many disease conditions.

10 Oct 2011

Cannabidiol could prevent onset of pain associated with chemotherapy drugs

A chemical component of the marijuana plant could prevent the onset of pain associated with drugs used in chemo therapy, particularly in breast cancer patients, according to researchers at Temple University's School of Pharmacy.

7 Oct 2011

WSU to help develop alternatives to petroleum-based fuels and chemicals

U.S. Department of Agriculture Secretary Tom Vilsack yesterday announced that Washington State University (WSU) will receive a five-year, $40 million grant to help develop alternatives to petroleum-based fuels and chemicals.

3 Oct 2011

Tobacco companies deliberately kept findings of cancer-causing radioactive particles from the public

Tobacco companies knew that cigarette smoke contained radioactive alpha particles for more than four decades and developed "deep and intimate" knowledge of these particles' cancer-causing potential, but they deliberately kept their findings from the public, according to a new study by UCLA researchers.

29 Sep 2011

US researchers receive NIH grants to develop innovative neuroscience education programs

Eight investigators across the United States will receive funding over the next five years to develop innovative neuroscience education programs for K-12 students and their teachers. Activities described within some proposals include using touch tablet technology to teach neurobiology, and the creation of a 1,400-square-foot interactive learning center.

28 Sep 2011

U of A researchers discover active environmental catalyst

University of Alberta chemistry researchers have discovered an active catalyst that has the potential to improve the efficiency and environmental impact of manufacturing processes used to make products such as agrochemicals and pharmaceuticals.

28 Sep 2011

Low vitamin B12 raises risk of dementia in the elderly: Study

According to a latest study the elderly with low levels of vitamin B12 in their blood may be more likely to develop problems with their thinking skills and have more brain shrinkage. The study points to a link between low B12 and early cognitive decline, a condition that often leads to dementia. Previous research has found that those people with high levels of vitamin B12 in their blood have lower levels of an amino acid called homocysteine, which some studies have linked to an increased risk of Alzheimer's disease, memory loss, and stroke.

27 Sep 2011

Researchers modify HIV in a way that makes it no longer able to suppress immune system

Researchers at Johns Hopkins have modified HIV in a way that makes it no longer able to suppress the immune system. Their work, they say in a report published online September 19 in the journal Blood, could remove a major hurdle in HIV vaccine development and lead to new treatments.

27 Sep 2011

Fruits and veggies may prevent bowel cancer but not fruit juices: Study

Scientists claim that a glass of juice contains so much sugar it actually increases the risk of certain cancers, rather than preventing them. In fact, by the time the drink has been processed and packaged, many of the ingredients in fruit that protect against tumors have been lost, they say. The Perth team also said that many things found in fruit which help protect against bowel cancer – including fibre, vitamin C and chemicals known as antioxidants – are lost during the juice’s processing.

26 Sep 2011

Study examines link between mother's occupation and asthma prevalence among children

Mothers who are exposed to particular agents during pregnancy could give birth to children with a higher risk of asthma, according to new research.

26 Sep 2011

Anti-obesity drug Contrave may get another chance to prove itself

With rise obesity around the world there should have been a number of drugs to combat it. The reality is different. There are no safe and effective drugs in the market at present.

22 Sep 2011

BPA found in kids’ canned food

The chemical Bisphenol A (BPA) that is suspected to be harmful to babies may be found in several child-friendly canned foods. Breast Cancer Fund researchers tested for bisphenol A (BPA) in six products specifically marketed to children. Included in the list were such popular kid-targeted meals as Campbell’s “Disney Princess" soup with "shaped pasta with chicken in chicken broth” and Annie’s Homegrown certified organic “Cheesy Ravioli.” BPA, which is found in plastics, cash-register receipts, dental sealants and even money, has been linked in animal studies to a host of health ills, including possible cancers and developmental problems and early puberty.

22 Sep 2011

Sapheon's new varicose vein closure system receives European CE Mark approval

Sapheon Inc. announced that it has received CE Mark approval for its new approach to the treatment of varicose veins caused by venous reflux disease.

22 Sep 2011

Three Johns Hopkins scientists receive NIH Director's New Innovator Awards

A pioneer in the field of epigenetics who has been spearheading the use of genome-wide technology for epigenetics research, a researcher who has revealed a weakness in the tuberculosis bacterium that makes it more susceptible to antibiotics, and a scientist who seeks to revolutionize new methods for toxicological testing to improve human health and reduce animal testing have received Director's Awards from the National Institutes of Health.

22 Sep 2011

New floating microscopic device for researchers to study wide range of cellular processes

It's a bit of a challenge. But, imagine a microscopic jet vacuum cleaner, the size of a pen nib that hovers over cell surfaces without ever touching them. Then imagine that the soap in the cleaning solution is replaced with various molecules that can be selectively delivered to the cells. This gives you a sense of a new device that researchers believe will serve as a powerful tool to study the behaviour of living cells and a range of crucial cellular processes, from cancer cell formation to how neurons align themselves in the developing brain.

21 Sep 2011

New UTHealth toll-free helpline for pregnant women to avoid dangerous medications

A new toll-free helpline developed to help pregnant women avoid medications and other substances that can cause birth defects has been launched by The University of Texas Health Science Center at Houston (UTHealth) for the Texas Department of State Health Services.

20 Sep 2011

Roxon plans to propagate tough stands on tobacco packaging

Health Minister Nicola Roxon plans to encourage other countries to follow Australia's push for plain-packaged tobacco at a major United Nations summit on chronic diseases today.

19 Sep 2011

ALS damages neurons in parts of the brain responsible for cognition and behaviour

Recently published studies by a researcher in the Faculty of Medicine & Dentistry demonstrate that ALS - known as Lou Gehrig's disease - damages neurons in parts of the brain responsible for cognition and behaviour.

17 Sep 2011

Chemicals News and Research

NovaSterilis awarded patent for sterilization process for pharmaceutical API using supercritical carbon dioxide

Aspirin desensitization procedure can benefit patients with sinusitis, asthma and AERD

New siRNA treatment reduces damaging inflammation in animals models of several disorders

Cannabidiol could prevent onset of pain associated with chemotherapy drugs

WSU to help develop alternatives to petroleum-based fuels and chemicals

Tobacco companies deliberately kept findings of cancer-causing radioactive particles from the public

US researchers receive NIH grants to develop innovative neuroscience education programs

U of A researchers discover active environmental catalyst

Low vitamin B12 raises risk of dementia in the elderly: Study

Researchers modify HIV in a way that makes it no longer able to suppress immune system

Fruits and veggies may prevent bowel cancer but not fruit juices: Study

Study examines link between mother's occupation and asthma prevalence among children

Anti-obesity drug Contrave may get another chance to prove itself

BPA found in kids’ canned food

Sapheon's new varicose vein closure system receives European CE Mark approval

Three Johns Hopkins scientists receive NIH Director's New Innovator Awards

New floating microscopic device for researchers to study wide range of cellular processes

New UTHealth toll-free helpline for pregnant women to avoid dangerous medications

Roxon plans to propagate tough stands on tobacco packaging

ALS damages neurons in parts of the brain responsible for cognition and behaviour

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo